Biomedicine. Protein loss in cancer cachexia.
Tisdale
M J
MJ
Pharmaceutical Sciences Research Institute, Aston University, Birmingham B4 7ET, UK.
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D002100:Cachexia / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D002454:Cell Differentiation; D003546:Cysteine Endopeptidases / Q000235:genetics / Q000378:metabolism; D016207:Cytokines / Q000494:pharmacology; D006706:Homeostasis; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D051379:Mice; D009097:Multienzyme Complexes / Q000235:genetics / Q000378:metabolism; D009124:Muscle Proteins / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000166:cytology / Q000378:metabolism* / Q000473:pathology; D017570:MyoD Protein / Q000235:genetics / Q000378:metabolism; D009218:Myosins / Q000235:genetics / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism*; D009369:Neoplasms / Q000150:complications*; D011401:Promoter Regions, Genetic; D046988:Proteasome Endopeptidase Complex; D011509:Proteoglycans; D014158:Transcription, Genetic; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014452:Ubiquitins / Q000378:metabolism
D001798:Blood Proteins; D016207:Cytokines; D009097:Multienzyme Complexes; D009124:Muscle Proteins; D017570:MyoD Protein; D016328:NF-kappa B; D011509:Proteoglycans; D014409:Tumor Necrosis Factor-alpha; D014452:Ubiquitins; C042057:proteolysis-inducing peptide; D007371:Interferon-gamma; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex; D009218:Myosins